Pressemitteilungen

Finnish medtech company Nukute successfully closes its series A funding round and goes after COVID-19 – receives a strategic three million euro investment from the Pharmacy Pension Fund (Finland)

Medtech company Nukute raised funding of €4.1 million on its series A round, €4.9 million with public funding included. The single largest investment came from the Pharmacy Pension Fund (Finland), that believed in Nukute’s business with an investment of €3.0 million. The company is moving forward with clinical trials and the obtaining of the CE marking for the added functionality to the Nukute...